Multiplex Cell Technology (Cell Therapy) Equipment
1 equipment items found
-
based in USA
Our next-generation chRDNA genome-editing platform is the foundation for the development of differentiated allogeneic cell therapies. Our chRDNA technology enables multiple genome edits, including multiplex gene insertions, with a high degree of specificity and lower levels of off-target editing than first generation CRISPR-Cas9. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you